Timothy Cloughesy is a Neurology physician affiliated with University of California, Los Angeles. OpenAlex indexes 1,354 publications with 64,062 citations (h-index 129); ClinicalTrials.gov lists 14 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Medical Plaza Suite B-200
Los Angeles, CA 900950001
Telephone
310-794-1195Provider last certified this registry record 16 Jan 2020.
Clinical trials
- Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
Sponsor: Jonsson Comprehensive Cancer Center
- 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
Sponsor: Jonsson Comprehensive Cancer Center
- Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
Sponsor: Jonsson Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim RCV GmbH & Co KGProgram year20254 payments
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- Exelixis Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
University of California Los Angeles
FY2026$591,984R01CA270027 - Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
University of California Los Angeles
FY2025$607,842R01CA270027 - Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
University of California Los Angeles
FY2024$587,142R01CA270027
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”